BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site
about
DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFFStructure of the extracellular domains of human and Xenopus Fn14: implications in the evolution of TWEAK and Fn14 interactionsTWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modulesPrinciples of antibody-mediated TNF receptor activationExploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTERPotent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myelomaCross-strand interactions of fluorinated amino acids in β-hairpin constructs.Synthetic antibodies as therapeutics.Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicryStoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.An APRIL to remember: novel TNF ligands as therapeutic targets.Binding efficiency of protein-protein complexes.The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.Relationship between hot spot residues and ligand binding hot spots in protein-protein interfaces.Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.Manipulating B cell homeostasis: a key component in the advancement of targeted strategiesDevelopment of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics.A complex water network contributes to high-affinity binding in an antibody-antigen interface.Engineering an APRIL-specific B cell maturation antigen.BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors.
P2860
Q24309087-B740EE5B-7D8F-4B33-BF3E-BC2BCC3FCB93Q24320262-18722FB5-A8B8-4AB8-B8DE-070FE41737B8Q24553352-EEAE75DD-B013-4624-A9CB-8CE4A07D9A37Q26796270-F787D81C-4E4C-481B-B359-3215516A9D37Q27678523-EEF0512E-AD89-40F2-B63F-82B5A5CD189BQ27700745-4C97320E-9394-4389-99AE-742CF4F65E24Q30573961-4F7B5F42-7CCE-4CD2-96F9-E4B78E24BE5FQ33265617-8A380827-A8F3-40A0-97A9-2B55F0C7272BQ33368623-389045FD-F0A3-4D99-941F-7875250080E1Q33688370-9B3EC90B-A6E2-4ADD-BA7F-8724A87661C3Q35783159-B1EB10DD-C29A-43E2-A8AD-DDE5CC7A3A76Q36394955-7C3BD557-849E-4FE1-8940-9B3977128808Q36595042-0825DA2E-E991-447F-AA26-AAF0D879649CQ36622367-1CF59268-E8EF-4EE5-ACF6-74422DD05375Q36758601-B8E83299-354C-4B2D-BED8-ABC7B0023C41Q36797904-6BDF8DA5-BBAD-4B3E-B887-6E2AA2ADDB6BQ37177128-F11C9ED5-5759-4651-A6E3-03CDE930BFAFQ38673541-2762596E-D612-41AA-85E5-E934ACDE1708Q40008767-5B29E085-32B3-4102-AFD5-4DE56098A9BEQ44756940-9B7C9BFE-5E13-4B72-B37F-9F9C9FEF9114Q52639397-DBA39FF0-6FAB-4748-90D5-526F8D254CFEQ55027807-A335D06E-F3AF-40E1-8D77-F9E73070E374
P2860
BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@ast
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@en
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@nl
type
label
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@ast
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@en
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@nl
prefLabel
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@ast
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@en
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@nl
P2093
P356
P1433
P1476
BAFF/BLyS receptor 3 comprises ...... ly focused ligand-binding site
@en
P2093
Borlan Pan
JianPing Yin
Melissa A Starovasnik
Minhong Yan
Nathaniel C Gordon
Robert F Kelley
Sarah G Hymowitz
Vishva M Dixit
Wayne J Fairbrother
P304
P356
10.1021/BI034017G
P407
P577
2003-05-27T00:00:00Z